BIOHAVEN PHARMACTL HLDG CO L's ticker is BHVN and the CUSIP is G11196105. A total of 247 filers reported holding BIOHAVEN PHARMACTL HLDG CO L in Q4 2020. The put-call ratio across all filers is 0.72 and the average weighting 0.7%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2022 | $3,271,000 | +19.8% | 21,635 | +15.5% | 0.01% | +33.3% |
Q2 2022 | $2,730,000 | +9.2% | 18,737 | -11.1% | 0.01% | +20.0% |
Q1 2022 | $2,500,000 | -22.8% | 21,081 | -10.2% | 0.01% | -16.7% |
Q4 2021 | $3,237,000 | -18.8% | 23,488 | -18.1% | 0.01% | -14.3% |
Q3 2021 | $3,984,000 | +414.7% | 28,683 | +259.9% | 0.01% | +600.0% |
Q2 2021 | $774,000 | -43.5% | 7,970 | -60.2% | 0.00% | -50.0% |
Q1 2021 | $1,369,000 | -21.0% | 20,027 | -0.9% | 0.00% | -33.3% |
Q4 2020 | $1,733,000 | +4.6% | 20,217 | -20.7% | 0.00% | 0.0% |
Q3 2020 | $1,657,000 | +94.0% | 25,487 | +118.1% | 0.00% | +200.0% |
Q2 2020 | $854,000 | -4.8% | 11,685 | -55.7% | 0.00% | -50.0% |
Q1 2020 | $897,000 | +311.5% | 26,370 | +353.5% | 0.00% | – |
Q3 2018 | $218,000 | – | 5,815 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
RP Management, LLC | 1,111,111 | $107,867,000 | 52.60% |
Knoll Capital Management, LLC | 856,844 | $83,182,000 | 43.44% |
ORACLE INVESTMENT MANAGEMENT INC | 2,082,555 | $202,174,000 | 27.86% |
ARS Investment Partners, LLC | 558,286 | $54,198,000 | 5.52% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 176,400 | $17,113,000 | 4.52% |
KINGDON CAPITAL MANAGEMENT, L.L.C. | 401,006 | $38,930,000 | 4.51% |
Eventide Asset Management | 1,990,797 | $193,267,000 | 2.60% |
SILVERARC CAPITAL MANAGEMENT, LLC | 56,626 | $5,497,000 | 2.45% |
Avidity Partners Management LP | 882,500 | $85,673,000 | 2.32% |
Nicholas Investment Partners, LP | 363,708 | $35,309,000 | 2.22% |